Fundz
Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Genomics Plc Appoints David Thornton As President, Succeeding Professor Gil Mc Vean

PRIVATESep 30, 2024•over 1 year ago

Position

President

Company

Genomics plc

David Thornton
OxfordBiotechnologyHealth CareMedical

Description

Genomics plc has appointed David Thornton as President, succeeding Professor Gil McVean, who will join the board as a non-executive Director. The Founder & CEO Professor Sir Peter Donnelly will continue to be responsible for the overall strategy, with this appointment also allowing him to take on a more outward-facing role for the business as it continues its growth journey.

Company Information

Company

Genomics plc

Location

Oxford, England, United Kingdom

About

Genomics plc is a pioneering healthcare company that uses large-scale genetic information to develop innovative precision healthcare tools and bring new understanding to drug discovery. It collaborates with some of the world's leading healthcare organizations and aims to predict, prevent, treat, and cure common diseases like cancer, diabetes, and heart disease.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Genomics plc's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.